STOCK TITAN

Marc Stapley (NASDAQ: VCYT) reports sale of 15,000 shares for $1.92M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Marc Stapley reported a sale of 15,000 common shares on 01/22/2026, with proceeds shown as $1,915,576.23. The filing also lists intended issuer-side units: 34,398 Performance Stock Units dated 02/26/202611,125 Restricted Stock Units dated 03/02/2026

The transactions are reported on a Form 144 and the sale was routed through Morgan Stanley Smith Barney LLC on the NASDAQ market.

Positive

  • None.

Negative

  • None.

Insights

Reported open-market sale with accompanying issuer-side units listed.

The filing records a reported disposition of $1,915,576.23 from the sale of 15,000 common shares on 01/22/202634,398 Performance Stock Units (02/26/2026) and 11,125 Restricted Stock Units (03/02/2026) as securities to be sold by the issuer.

Cash‑flow treatment and any holder attribution beyond the named reporting person are not detailed in the excerpt; subsequent filings or broker confirmations would show settlement and exact proceeds allocation.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Marc Stapley report in the Form 144 for VCYT?

He reported selling 15,000 common shares on 01/22/2026 for $1,915,576.23. The filing also lists issuer-side units: 34,398 Performance Stock Units (02/26/2026) and 11,125 Restricted Stock Units (03/02/2026) as securities to be sold.

Which broker handled the reported VCYT transaction?

The sale was routed through Morgan Stanley Smith Barney LLC at the address shown in the filing. The execution venue listed is NASDAQ, as recorded in the Form 144 excerpt.

Are there other securities listed in the VCYT filing besides the 15,000 shares?

Yes. The filing lists 34,398 Performance Stock Units dated 02/26/202611,125 Restricted Stock Units dated 03/02/2026 as securities to be sold by the issuer.

Does the Form 144 show the cash proceeds recipient for the VCYT sale?

The excerpt shows proceeds of $1,915,576.23 for the 15,000-share sale. The filing does not detail who ultimately received the cash beyond the sale record shown in the excerpt.

When were the listed Performance Stock Units and RSUs dated in the VCYT filing?

The Performance Stock Units are dated 02/26/2026 and the Restricted Stock Units are dated 03/02/2026, as shown in the Form 144 securities table.
Veracyte

NASDAQ:VCYT

VCYT Rankings

VCYT Latest News

VCYT Latest SEC Filings

VCYT Stock Data

2.77B
78.54M
Diagnostics & Research
Services-medical Laboratories
Link
United States
SOUTH SAN FRANCISCO